+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effects of antipsychotics with 5-HT2C receptor affinity in behavioral assays selective for 5-HT2C receptor antagonist properties of compounds



The effects of antipsychotics with 5-HT2C receptor affinity in behavioral assays selective for 5-HT2C receptor antagonist properties of compounds



European Journal of Pharmacology 388(1): 57-67



Many antipsychotics have marked antagonist effects at 5-hydroxytryptamine (5-HT(2C)) receptors in vitro, which, however, have been difficult to show in behavioral assays. Here, we used two assays - hypolocomotion and hypophagia induced by the 5-HT(2C) receptor agonist 1-(3-chlorophenyl)piperazine (mCPP) - to try to characterize the 5-HT(2C) receptor antagonist properties of antipsychotics in vivo. Clozapine, olanzapine, pipamperone, and trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz-[2,3:6, 7]oxepino[4,5-C] pyrrolidino maleate (ORG 5222), modestly, but significantly, attenuated mCPP (10 mg/kg)-induced hypolocomotion. In contrast, risperidone and loxapine were inactive. The putative antipsychotic ORG 5222 significantly attenuated mCPP (5 mg/kg)-induced hypophagia, whereas the other antipsychotics were inactive. Selective antagonists at dopamine D(2)-like receptors, alpha(1)-adrenoceptors, alpha(2)-adrenoceptors, or muscarinic receptors were not able to antagonize the effects of mCPP in either assay. The results suggest that mCPP-induced hypolocomotion can be used to characterize the 5-HT(2C) receptor antagonist properties of antipsychotics, whereas mCPP-induced hypophagia appeared to be sensitive only to compounds highly selective for 5-HT(2C) receptors. Together, these assays may help to characterize functional, in vivo, 5-HT(2C) receptor antagonist properties of antipsychotics.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011499677

Download citation: RISBibTeXText

PMID: 10657547

DOI: 10.1016/s0014-2999(99)00859-6


Related references

Anxiety-related behaviours on the unstable elevated exposed plus maze are enhanced by meta-chlorophenylpiperazine, a 5-HT2C/2B receptor agonist, and inhibited by SB 242084, a selective 5-HT2C receptor antagonist. Society for Neuroscience Abstracts 26(1-2): Abstract No -659 7, 2000

Antagonist properties of atypical antipsychotics at the 5-HT2C receptor. FASEB Journal 17(4-5): Abstract No 643 4, 2003

Biochemical and Behavioral Pharmacology of RS-102221, a Subtype Selective 5-HT2c Receptor Antagonist. Cns Drug Reviews 3(3): 278-293, 1997

Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model. Neuropharmacology 70: 112-121, 2013

Absorption and brain penetration of a high affinity, highly selective 5-HT2C receptor antagonist, RS-102221. Annals of the New York Academy of Sciences 861: 269, 1999

The 5-HT2C receptor mediates selective antidepressant-like behavioral effects. Society for Neuroscience Abstracts 26(1-2): Abstract No -46 11, 2000

(+)-cis-4,5,7a,8,9,10,11,11a-Octahydro-7H-10-methylindolo[1,7-bc][2,6]- naphthyridine: A 5-Ht2C/2B Receptor Antagonist with Low 5-Ht2A Receptor Affinity. Journal of Medicinal Chemistry 38(1): 28-33, 1995

(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinity. Journal of Medicinal Chemistry 38(1): 28-33, 1995

Effects of SB 242084, a selective 5 - HT2c receptor antagonist, on m - CPP - induced hypophagia in ob/ob mice. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 509 10, 2003

Effects of selective 5-HT2C receptor antagonist, SB 242084, on anxiety and depressive-like behaviour in mice. European Neuropsychopharmacology 10(Suppl. 3): S344, 2000

The selective 5-HT2C/2B receptor antagonist SB221284 enhances the behavioural and biochemical effects of morphine in mice. British Journal of Pharmacology 126(PROC Suppl. ): 237P, 1999

Effects of a selective 5-HT2C receptor antagonist, SB242084 on penile erections induced by mCPP, apomorphine and MT-II. Society for Neuroscience Abstracts 27(2): 2546, 2001

Examination of recently developed 5-HT2C receptor agonists for agonist-trafficking of 5-HT2C receptor stimulated functional response. Society for Neuroscience Abstracts 25(1-2): 1199, 1999

Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2c receptor inverse agonist but fails to induce 5-HT2c receptor down-regulation. Psychopharmacology. 136(2): 99-104, Ch, 1998

Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice. Bmc Pharmacology 11: 3, 2011